APA (7th ed.) Citation

W, H., C, T., EB, B., & BS, T. (2022). Prognostic and predictive impact of MGMT promoter methylation status in high risk grade II glioma. Journal of neuro-oncology, 157(1), 137. https://doi.org/10.1007/s11060-022-03955-3

Chicago Style (17th ed.) Citation

W, Haque, Teh C, Butler EB, and Teh BS. "Prognostic and Predictive Impact of MGMT Promoter Methylation Status in High Risk Grade II Glioma." Journal of Neuro-oncology 157, no. 1 (2022): 137. https://doi.org/10.1007/s11060-022-03955-3.

MLA (9th ed.) Citation

W, Haque, et al. "Prognostic and Predictive Impact of MGMT Promoter Methylation Status in High Risk Grade II Glioma." Journal of Neuro-oncology, vol. 157, no. 1, 2022, p. 137, https://doi.org/10.1007/s11060-022-03955-3.